Skip to main content

EQT — Portfolio, Page 6

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

299
Companies
$5.9B
Total invested
$173.9M
Avg. check
61
Industries
Biotechnology 8Health Care 5Software 4Financial Services 3FinTech 3Pharmaceutical 3+55 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 121–144 of 299
Kasada
December 2025

Kasada protects online, mobile, and API channels from system takeover, content scraping, DOS, and account takeover.

Computer · Sydney$19.9M Venture - Series Unknown
Mambu
December 2021

Mambu is the only true SaaS cloud core banking platform.

Banking · Amsterdam$265.4M Series E
Tenpoint Therapeutics
January 2026

Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

Biotechnology · Camborne$150.0M Debt Financing
Atalanta Therapeutics
January 2025

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.

Biotechnology · Boston$97.0M Series B
FastAF Technologies
December 2021

FastAF Technologies is a commerce retailer that delivers essential products.

Delivery Service · San Francisco$50.0M Series A
Watt Fuel Cell
December 2022

WATT Fuel Cell is a developer and manufacturer of solid oxide fuel cell stacks.

Energy · Mount Pleasant Mills$82.3M Corporate Round
Onramper
January 2022

Onramper is an app that allows users to convert fiat currency into cryptocurrency.

Apps · Amsterdam$6.0M Seed
Wandelbots
January 2022

Wandelbots is a robotic software company. It enables the programming free and uniform operation of robots.

Industrial Automation · Dresden$84.0M Series C
Darkstore
December 2022

At Darkstore we build technology to power large scale micro fulfillment and instant delivery logistics.

Delivery · San Francisco$1.0M Undisclosed
FoRx Therapeutics
December 2025

FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.

Biotechnology · Basel$50.0M Series A
SeeQC
January 2026

SeeQC is a semiconductor company that develops quantum computing systems and offers chip fabrication services to businesses.

Electronics · Elmsford$19.2M Venture - Series Unknown
Noema Pharma
December 2024

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

Biotechnology · Basel$147.2M Series B
Exciva
January 2026

Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms associated with dementia.

Biotechnology · Heidelberg$59.4M Series B
INNOVO by Atlantic Therapeutics
January 2022

INNOVO by Atlantic Therapeutics is a medical technology firm that develops pelvic floor muscle strengthening and nerve stimulation products.

Fitness · Galway$20.4M Venture - Series Unknown
Anyfin
January 2023

Anyfin - a smart finance app that empowers people to understand and improve their finances.

Consumer Lending · Stockholm$31.3M Series C
Formo
January 2025

Formo is a cell-ag company that develops animal-free dairy products using nature-identical milk proteins from precision fermentation.

Biotechnology · Berlin$36.1M Debt Financing
TreeCard
November 2022

Treecard is a fullstack green finance platform, allowing consumers to spend, save and invest responsibly.

Banking · London$22.9M Series A
Timeless
November 2021

Buy shares in exclusive assets such as rare sneakers, watches & luxury cars from as little as €50 per share (incl. VAT).

E-Commerce · Berlin$13.6M Venture - Series Unknown
Getvoila
January 2025

Germany's best chefs & restaurants, delivered nationwide. Perfect for special occasions, holidays and Christmas.

Food and Beverage · BerlinVenture - Series Unknown
Permutive
November 2021

Permutive is an audience platform for advertisers and publishers to plan, build, and activate cohorts while keeping everyone’s data safe.

Advertising · LondonSeries C
ATB Therapeutics
November 2024

ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

Biotechnology · Aye$57.2M Series A
Pruna AI
November 2024

Making AI accessible & sustainable

Artificial Intelligence (AI) · Munich$6.5M Seed
Artios Pharma
November 2025

Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.

Biopharma · Cambridge$115.0M Series D
AnyDesk
November 2021

AnyDesk is a remote desktop application.

Apps · Stuttgart$67.9M Series C

Where EQT invests

Biotechnology8
Health Care5
Software4
Financial Services3
FinTech3
Pharmaceutical3

About EQT's portfolio

How many companies has EQT invested in?▸

EQT has invested in 299 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does EQT invest in?▸

EQT's top investment sectors include Biotechnology, Health Care, Software, Financial Services, FinTech. The firm invests across 61 different industry categories.

What is EQT's largest investment?▸

Among tracked funding rounds, Mambu received $265.4M in a Series E round. EQT's total known invested capital is $5.9B.

What is the average investment size for EQT?▸

EQT's average investment size is $173.9M across its portfolio of 299 companies.

What are EQT's most recent investments?▸

Recent EQT portfolio additions include Kasada, Mambu, Tenpoint Therapeutics, Atalanta Therapeutics, FastAF Technologies. These companies were founded in 2020 or later.

Reach the founders behind these 299 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →